We are live on ! Find out more
SONM icon

DNA X Inc

8 hedge funds and large institutions have $291K invested in DNA X Inc in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.1% more ownership

Funds ownership: 0.01%0.12% (+0.1%)

47% less funds holding

Funds holding: 158 (-7)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

74% less capital invested

Capital invested by funds: $1.13M → $291K (-$838K)

Holders
8
Holders Change
-7
Holders Change %
-46.67%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
9
Calls
Puts
Net Calls
Net Calls Change

SONM Hedge Fund Activity: Q3 2024 in Review

8 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q3 2024, worth a combined $291K — down 74% from $1.13M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SONM and 3 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $71.6K. The largest seller was Sicart Associates, exiting entirely with an estimated $407K sold.

  • 8 institutional investors held DNA X Inc (SONM) as of Q3 2024, down from 15 in Q2 2024.
  • Funds reported $291K of DNA X Inc stock for Q3 2024, down 74% quarter-over-quarter.
  • 3 funds opened new DNA X Inc positions in Q3 2024 and 9 closed out, a net change of -6 holders.
  • The largest DNA X Inc buyer in Q3 2024 was Vanguard Group, an estimated $71.6K added.
  • The largest DNA X Inc seller in Q3 2024 was Sicart Associates, an estimated $407K sold.

Based on aggregated 13F filings for Q3 2024.